Correlation Between Neuropace and Inari Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Inari Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Inari Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Inari Medical, you can compare the effects of market volatilities on Neuropace and Inari Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Inari Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Inari Medical.

Diversification Opportunities for Neuropace and Inari Medical

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Neuropace and Inari is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Inari Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inari Medical and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Inari Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inari Medical has no effect on the direction of Neuropace i.e., Neuropace and Inari Medical go up and down completely randomly.

Pair Corralation between Neuropace and Inari Medical

Given the investment horizon of 90 days Neuropace is expected to generate 1.54 times more return on investment than Inari Medical. However, Neuropace is 1.54 times more volatile than Inari Medical. It trades about 0.06 of its potential returns per unit of risk. Inari Medical is currently generating about 0.0 per unit of risk. If you would invest  723.00  in Neuropace on October 5, 2024 and sell it today you would earn a total of  434.00  from holding Neuropace or generate 60.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Inari Medical

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Inari Medical 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Inari Medical are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly abnormal basic indicators, Inari Medical demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Neuropace and Inari Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Inari Medical

The main advantage of trading using opposite Neuropace and Inari Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Inari Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inari Medical will offset losses from the drop in Inari Medical's long position.
The idea behind Neuropace and Inari Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets